Abstract
Chemical carcinogenesis in certain tissues occurs in at least two stages: initiation, producing irreversible tissue alterations, and promotion (by agents, themselves non-carcinogenic), enhancing the outgrowth of transformed cells1,2. Among the various tumour-promoting compounds isolated from croton oil, phorbol-12-myristate-13-acetate (PMA), is the most potent3. Cell culture studies have shown that the phorbol diesters and structurally related substances induce a variety of dramatic changes in diverse eukaryotic cells. Spreading, differentiation, metabolism, DN A synthesis, expression of cell surface glycopeptides, deoxyglucose transport, as well as polyamine, plasminogen activator and ornithine decarboxylase activity are altered4–6. These findings indicate that tumour promoters potentiate expression of the transformed phenotype in cells already malignantly transformed and also induce reversible manifestations of the transformed phenotype in normal cells4. It is not known whether these agents additionally influence host effector systems involved in antitumour resistance7–11. The present study is concerned with the effects of PMA on spontaneous in vitro cytotoxicity by macrophages and/or natural killer (NK) cells, and on the resistance to rat fibrosarcoma in vivo considered to depend on these normal effectors, in particular on mononuclear phagocytes12.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berenblum, I. in Cancer Vol 1, 323–344 (Plenum, New York, 1975).
Boutwell, R. K. CRC crit. Rev. Toxic. 2, 419–443 (1974).
Hecker, E. Meth. Cancer Res. 6, 439–484 (1971).
Weinstein, I. B., Wigler, M. & Pietropaolo, C. in Origins of Human Cancer, 751–772 (ColdSpring Harbor, 1977).
Driedger, P. E. & Blumberg, P. M. Cancer Res. 37, 3257–3265 (1977).
Chan, T.-S. Proc. natn. Acad. Sci. U.S.A. 76, 925–929 (1979).
Touraine, J.-L. et al. J. exp. Med. 145, 460–465 (1977).
Nathan, C. F., Brukner, L. H., Silverstein, S. C. & Conn, Z. A. J. exp. Med. 149, 84–99 (1979).
Holdal, J. R., Repine, J. E., Beall, G. D., Rasp, F. L. & White, J. G. Am. J. Path. 91, 469–482 (1978).
Brune, K., Glatt, M., Kälin, H. & Peskar, B. A. Nature 274, 261–263 (1978).
Shoyab, M., deLarco, J. E. & Todaro, G. J. Nature 279, 387–391 (1979).
Keller, R. in Functional Aspects of Mononuclear Phagocytes (Martinus Nijhoff B.V., The Hague, in the press).
Nelson, D. S. Immunobiology of the Macrophage (Academic New York, 1976).
Keller, R. in Current Trends in Tumor Immunology (Garland STMP, New York, in the press).
James, K., McBride, W. H. & Stuart, A. The Macrophage and Cancer (Univ. Edinburgh, 1977).
Keller, R. Br. J. Cancer 37, 732–741 (1978).
Möller, G. (ed.) Natural Killer Cells. Immun. Rev. 44 (1979).
Herberman, R. B. et al. Immun. Rev. 44, 43–70 (1979).
Stadecker, M. J., Calderon, M., Karnovsky, M. L. & Unanue, E. R. J. Immun. 119, 1738–1743 (1977).
Keller, R. & Keist, R. Br. J. Cancer 37, 1078–1082 (1978).
Nathan, C. F., Silverstein, S. C., Brukner, L. H. & Cohn, Z. A. J. exp. Med. 149, 100–113 (1979).
Kiessling, R., Klein, E. & Wigzell, H. Eur. J. Immun. 5, 112–117 (1975).
Keller, R. J. natn. Cancer Inst. 59, 1751–1753 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Keller, R. Suppression of natural antitumour defence mechanisms by phorbol esters. Nature 282, 729–731 (1979). https://doi.org/10.1038/282729a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/282729a0
This article is cited by
-
Suppression of the antibody response by phorbol esters in the mouse is due to an effect on the nylon wool adherent cell population
Agents and Actions (1985)
-
Host defense mechanisms against tumors as the principal targets of tumor promoters
Journal of Cancer Research and Clinical Oncology (1983)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.